BioCentury
ARTICLE | Top Story

Axcan raises $110 million

February 28, 2003 8:00 AM UTC

Gastroenterology company Axcan (AXCA; TSE:AXP) raised $110 million in a bumped up convertible note deal. The notes bear 4.25% interest, mature in 2008 and convert into AXCA stock at $14.01. On Monday,...